# Wells Fargo & Company

Type: Company (WFC)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/wells-fargo-company
Canonical HTML page: https://getfinancebrief.com/entity/wells-fargo-company

## Timeline

- **2026-08-14**: Dividend Payment Date — Quarterly dividend paid to shareholders of record July 24.
- **2026-08-08**: Wall Street Zen cuts STAG and ZVIA to Sell — Wall Street Zen downgraded both Stag Industrial and Zevia PBC from hold to sell in weekend research notes.
- **2026-08-05**: ZVIA reports Q2 results — Zevia PBC reported EPS of -$0.03, hitting consensus, and revenue of $45.00 million versus a $44.21 million estimate.
- **2026-07-31**: Weiss reiterates buy on STAG; Baird sets $138 target — Weiss Ratings reiterated a buy (b-) rating on Stag Industrial, while Robert W. Baird set a $138.00 target price.
- **2026-07-28**: STAG reports Q2 earnings miss — Stag Industrial reported EPS of $0.28, missing the consensus estimate of $0.65 by $0.37; revenue was approximately $224 million.
- **2026-07-24**: Dividend Record Date — Shareholders of record qualify for $0.77 quarterly dividend.
- **2026-07-22**: Q2 Earnings Release — Kaiser Aluminum reports EPS $5.53, beats estimates by $2.87; revenue $1.26B surpasses $1.12B estimate.
- **2026-07-17**: Weiss Ratings upgrades ZVIA within sell range — Weiss Ratings raised shares of Zevia PBC from a sell (e+) rating to a sell (d-) rating.
- **2026-07-16**: Barclays raises STAG target but stays Underweight — Barclays boosted its price objective on Stag Industrial from $38.00 to $41.00 and maintained an underweight rating.
- **2026-07-09**: Wells Fargo Reaffirms Underweight — Wells Fargo reiterates underweight rating, sets $158 price target.
- **2026-07-08**: Wells Fargo Cuts Target to $70 — Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
- **2026-07-08**: UBS Lifts Price Target — UBS raises Kaiser Aluminum target to $179 from $176, maintains neutral rating.
- **2026-07-01**: Bank of America Lowers Target — Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
- **2026-06-15**: Piper Sandler Stays Overweight — Piper Sandler reaffirms an Overweight rating on Freshpet shares.
- **2026-06-01**: Weiss Ratings Downgrades — Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.

## Recent coverage (11 stories)

### STAG Downgraded to Sell as Price Sits 38% Below $50.50 Target
2026-08-13 00:19:12 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen cut Stag Industrial to sell, putting a fresh bearish tilt on a REIT whose shares opened at $36.68 versus a $50.50 consensus target. The same firm also downgraded Zevia PBC as its major shareholder trimmed a 15.87% stake.
Full story: https://getfinancebrief.com/story/stag-industrial-wall-street-zen-sell-downgrade

### SoFi Stock Surges 3.7% to $18.70 Despite 5 Analyst Target Cuts – What’s Next?
2026-08-12 13:34:09 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

SoFi Technologies shares jumped 3.7% on August 4, 2026, even as multiple analysts slashed price targets, creating a tension between market momentum and cautious research. With a PE of 38.96, beta of 2.17, and consensus Hold rating, the fintech’s next move hinges on whether profitability can catch up with valuation.
Full story: https://getfinancebrief.com/story/sofi-stock-surges-3-7-percent-analyst-target-cuts

### Wells Fargo Slashes CHKP Target to $130: 13.01 P/E and Consensus Hold Demand Attention
2026-08-12 13:16:01 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo lowered Check Point's target to $130, highlighting a divided analyst community with an average target of $149.48. The stock's depressed valuation and low beta present a potential value opportunity against high-growth cyber peers.
Full story: https://getfinancebrief.com/story/chkp-price-target-130-finance-analysis

### HC Wainwright Cuts Circle (CRCL) to $104, Still Sees 64% Upside
2026-08-07 01:20:20 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

HC Wainwright and Needham lowered price targets on Circle Internet Group but maintained Buy ratings as analysts remain split on the stablecoin issuer. The stock trades at $63.48, far below the consensus target of $100.06, highlighting both opportunity and risk.
Full story: https://getfinancebrief.com/story/circle-crcl-price-target-cut-finance

### Wabtec FY26 EPS $10.60-$10.90, Moody's $16.50-$17.00: Both Miss Consensus
2026-07-23 02:24:25 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wabtec guided revenue between $12.3-$12.6B and EPS slightly below the Street, while Moody’s EPS range also came in under estimates. Analysts remain constructive with moderate buy ratings and double-digit upside targets for both stocks.
Full story: https://getfinancebrief.com/story/wabtec-moodys-fy26-guidance-analysis

### Kaiser Aluminum EPS Beat by $2.87: Revenue Hits $1.26B, Shares Dip to $164.32
2026-07-23 00:53:05 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Kaiser Aluminum's Q2 2026 EPS of $5.53 blasts past estimates by 108%, with revenue reaching $1.26B. Despite the beat, the stock slipped 0.03% to $164.32 amid insider sales and mixed analyst targets. The $0.77 quarterly dividend and strong liquidity ratios offer some reassurance.
Full story: https://getfinancebrief.com/story/kaiser-aluminum-earnings-beat-eps-287-revenue-126b

### ResMed Targets Drop to $225 at Wells Fargo; Upside Remains at +23.2%
2026-07-10 14:15:12 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo’s $225 target is the lowest among major banks, yet ResMed’s average analyst target of $270.64 implies a 23.2% upside. Markets weigh defensive balance sheet qualities against emerging therapeutic competition.
Full story: https://getfinancebrief.com/story/resmed-stock-analyst-target-cuts-wells-fargo

### Wells Fargo Cuts Freshpet Target to $70, Still Sees 28% Upside
2026-07-09 13:12:08 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Full story: https://getfinancebrief.com/story/wells-fargo-cuts-freshpet-target-70-upside

### Raleigh Capital boosts VZ stake 33.7% – a $3.13M bet on Verizon's 6% yield
2026-07-06 07:06:29 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Raleigh Capital Management increased its Verizon position by a third in Q1 2026, joining other small institutional buyers. Despite VZ's recent price weakness and mixed analyst views, the defensive telecom's high dividend yield and 62% institutional ownership remain draws for income-focused portfolios.
Full story: https://getfinancebrief.com/story/raleigh-capital-boosts-vz-stake-33-percent

### Wells Fargo Downgrades O-I Glass to Equal Weight Amid Packaging Headwinds
2026-03-20 14:18:39 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo has lowered its rating on O-I Glass (NYSE: OI) from Overweight to Equal Weight, signaling a more cautious stance on the glass packaging giant. The move reflects broader industry challenges and a shift in analyst expectations regarding the company's near-term growth trajectory.
Full story: https://getfinancebrief.com/story/oi-glass-wells-fargo-downgrade-analysis

### AxoGen Surges as Wells Fargo Issues Rare 'Strong-Buy' Rating Upgrade
2026-02-21 01:12:47 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

AxoGen (NASDAQ: AXGN) has received a major boost from Wall Street as Wells Fargo upgraded the nerve-repair specialist to a 'Strong-Buy' rating. The upgrade follows a significant price target hike from Jefferies, signaling a robust consensus on the company's growth potential in the medical technology sector.
Full story: https://getfinancebrief.com/story/axogen-axgn-wells-fargo-strong-buy-upgrade

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.